- Positive phase three clinical trial results - combined efficacy of 70 per cent
- storage and transportation of the vaccine can be conducted at normal refrigerated conditions
IC TIP:
Buy
at
8179p
AstraZeneca (AZN), in conjunction with the University of Oxford, has released positive clinical trial results of its Covid-19 vaccine within days of Pfizer (NYSE: PFE) and BioNTech announcing that they were filing for emergency vaccine authorisation from the US Food and Drug Administration for their candidate.